2025 PSMA Conference
SAVE THE DATE
March 28-29, 2025
Renee Luskin Conference Center | Los Angeles, CA
Co-sponsored Event
This conference, co-sponsored by the University of California, San Francisco (UCSF) and the University of California, Los Angeles (UCLA), with support from the Prostate Cancer Foundation (PCF), will focus on the current and future use of PSMA PET imaging and radioligand therapy, including presentations, panel discussions, and exhibits from invited speakers and stakeholders.

Welcome

It is with delight and pleasure that we invite, and welcome you to the inaugural 2024 PSMA Conference, in-person or online.

Our Goals are to: 

  • Explain how to interpret PSMA PET scans
  • Discuss the selection of patients for PSMA radioligand therapy
  • Discuss patient management & potential toxicities for PSMA radioligand therapy

 

Image Source References

PSMA Illustration from O'Driscoll et al Br. J. Pharmocol. 2016, 173, 3041 Journal

O'Driscoll et al Br. J. Pharmocol. 2016, 173, 3041. The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.